WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012106540) METHODS OF USING ALK INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/106540    International Application No.:    PCT/US2012/023669
Publication Date: 09.08.2012 International Filing Date: 02.02.2012
IPC:
A61K 31/00 (2006.01), A61K 31/506 (2006.01), A61P 35/00 (2006.01)
Applicants: IRM LLC [US/US]; 131 Front Street P.O. Box HM 2899 Hamilton, HM LX (BM) (For All Designated States Except US).
LI, Nanxin [US/US]; (US) (For US Only).
HARRIS, Jennifer L. [US/US]; (US) (For US Only).
McNAMARA, Peter [IE/US]; (US) (For US Only).
SUN, Fangxian [US/US]; (US) (For US Only)
Inventors: LI, Nanxin; (US).
HARRIS, Jennifer L.; (US).
McNAMARA, Peter; (US).
SUN, Fangxian; (US)
Agent: TONGCO WU, Emily; Genomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, California 92121 (US)
Priority Data:
61/438,878 02.02.2011 US
Title (EN) METHODS OF USING ALK INHIBITORS
(FR) PROCÉDÉS D'UTILISATION D'INHIBITEURS D'ALK
Abstract: front page image
(EN)The invention provides methods for using compounds of Formula (I) for treating an EML4-ALK+ mediated condition such as EML4-ALK+ non-small cell lung cancer, and optionally resistant to crizotinib; wherein R1, R2, R3, R4, R5 and R6 are as defined above.
(FR)L'invention concerne des procédés pour utiliser des composés de formule (I) pour traiter une affection médiée par EML4-ALK+ telle que le cancer du poumon à grandes cellules EML4-ALK+, et facultativement résistant au crizotinib ; dans lequel R1, R2, R3, R4, R5 et R6 sont tels que définis ci-dessus.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)